Belite Bio, Inc ( BLTE) - Stock Earnings
BLTE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -21.7 million USD | — USD |
| 2025Q4 | -25.3 million USD | — USD |
| 2026Q1 | -26.9 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
BLTE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -31.6 million USD | — USD |
| 2024 | -36.1 million USD | — USD |
| 2025 | -77.6 million USD | — USD |
| 2026 Est. | — | — |
BLTE
Price: $144.31
52 week price:
Earnings Per Share: -2.54 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 5.7 billion